BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 30392727)

  • 1. Natural Products from Mammalian Gut Microbiota.
    Wang L; Ravichandran V; Yin Y; Yin J; Zhang Y
    Trends Biotechnol; 2019 May; 37(5):492-504. PubMed ID: 30392727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ecophylogenetics Clarifies the Evolutionary Association between Mammals and Their Gut Microbiota.
    Gaulke CA; Arnold HK; Humphreys IR; Kembel SW; O'Dwyer JP; Sharpton TJ
    mBio; 2018 Sep; 9(5):. PubMed ID: 30206171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of novel bioactive natural products driven by genome mining.
    Li Z; Zhu D; Shen Y
    Drug Discov Ther; 2018; 12(6):318-328. PubMed ID: 30674766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolite induction via microorganism co-culture: a potential way to enhance chemical diversity for drug discovery.
    Bertrand S; Bohni N; Schnee S; Schumpp O; Gindro K; Wolfender JL
    Biotechnol Adv; 2014 Nov; 32(6):1180-204. PubMed ID: 24651031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Omics and multi-omics approaches to study the biosynthesis of secondary metabolites in microorganisms.
    Palazzotto E; Weber T
    Curr Opin Microbiol; 2018 Oct; 45():109-116. PubMed ID: 29656009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gut metabolome meets microbiome: A methodological perspective to understand the relationship between host and microbe.
    Lamichhane S; Sen P; Dickens AM; Orešič M; Bertram HC
    Methods; 2018 Oct; 149():3-12. PubMed ID: 29715508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biogeography of Bacterial Communities and Specialized Metabolism in Human Aerodigestive Tract Microbiomes.
    Stubbendieck RM; Zelasko SE; Safdar N; Currie CR
    Microbiol Spectr; 2021 Oct; 9(2):e0166921. PubMed ID: 34704787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent Advances in Discovery of Lead Structures from Microbial Natural Products: Genomics- and Metabolomics-Guided Acceleration.
    Sukmarini L
    Molecules; 2021 Apr; 26(9):. PubMed ID: 33925414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting Bacterial Genomes for Natural Product Discovery.
    Kalkreuter E; Pan G; Cepeda AJ; Shen B
    Trends Pharmacol Sci; 2020 Jan; 41(1):13-26. PubMed ID: 31822352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Strategizing the human microbiome for small molecules: Approaches and perspectives.
    Hussain A; Patwekar U; Mongad DS; Shouche YS
    Drug Discov Today; 2023 Feb; 28(2):103459. PubMed ID: 36435302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploring and Understanding the Biochemical Diversity of the Human Microbiota.
    Koppel N; Balskus EP
    Cell Chem Biol; 2016 Jan; 23(1):18-30. PubMed ID: 26933733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioactive Secondary Metabolites from Octocoral-Associated Microbes-New Chances for Blue Growth.
    Raimundo I; Silva SG; Costa R; Keller-Costa T
    Mar Drugs; 2018 Dec; 16(12):. PubMed ID: 30518125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Understanding Competition and Cooperation within the Mammalian Gut Microbiome.
    Coyte KZ; Rakoff-Nahoum S
    Curr Biol; 2019 Jun; 29(11):R538-R544. PubMed ID: 31163167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Accessing Bioactive Natural Products from the Human Microbiome.
    Milshteyn A; Colosimo DA; Brady SF
    Cell Host Microbe; 2018 Jun; 23(6):725-736. PubMed ID: 29902438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gut Microbiota and Its Metabolites in Atherosclerosis Development.
    Pieczynska MD; Yang Y; Petrykowski S; Horbanczuk OK; Atanasov AG; Horbanczuk JO
    Molecules; 2020 Jan; 25(3):. PubMed ID: 32013236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A systematic analysis of biosynthetic gene clusters in the human microbiome reveals a common family of antibiotics.
    Donia MS; Cimermancic P; Schulze CJ; Wieland Brown LC; Martin J; Mitreva M; Clardy J; Linington RG; Fischbach MA
    Cell; 2014 Sep; 158(6):1402-1414. PubMed ID: 25215495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. From complex gut communities to minimal microbiomes via cultivation.
    Clavel T; Lagkouvardos I; Stecher B
    Curr Opin Microbiol; 2017 Aug; 38():148-155. PubMed ID: 28624689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of Reactive Microbiota-Derived Metabolites that Inhibit Host Proteases.
    Guo CJ; Chang FY; Wyche TP; Backus KM; Acker TM; Funabashi M; Taketani M; Donia MS; Nayfach S; Pollard KS; Craik CS; Cravatt BF; Clardy J; Voigt CA; Fischbach MA
    Cell; 2017 Jan; 168(3):517-526.e18. PubMed ID: 28111075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of peptides from honeybee gut symbionts as potential antimicrobial agents against Melissococcus plutonius.
    Lang H; Liu Y; Duan H; Zhang W; Hu X; Zheng H
    Nat Commun; 2023 Nov; 14(1):7650. PubMed ID: 38001079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Culture-independent discovery of natural products from soil metagenomes.
    Katz M; Hover BM; Brady SF
    J Ind Microbiol Biotechnol; 2016 Mar; 43(2-3):129-41. PubMed ID: 26586404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.